Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex—Compatibility Study with Pharmaceutical Excipients

Risperidone/Randomly Methylated β-Cyclodextrin Inclusion Complex—Compatibility Study with Pharmaceutical Excipients

Risperidone (RSP) is an atypical antipsychotic drug used in treating schizophrenia, behavioral, and psychological symptoms of dementia and irritability associated with autism. The drug substance is practically insoluble in water and exhibits high lipophilicity. It also presents incompatibilities wit...

Full description

Bibliographic Details
Main Authors: Laura Sbârcea, Ionuț-Mihai Tănase, Adriana Ledeți, Denisa Cîrcioban, Gabriela Vlase, Paul Barvinschi, Marinela Miclău, Renata-Maria Văruţ, Oana Suciu, Ionuț Ledeți
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Molecules
Subjects:
risperidone
inclusion complex
randomly methylated β-cyclodextrin
compatibility studies
excipients
solubility
Online Access:https://www.mdpi.com/1420-3049/26/6/1690

Internet

https://www.mdpi.com/1420-3049/26/6/1690

Similar Items